Focus on gastric cancer.
Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan 104-0045.
Toshikazu
T
Ushijima
Mitsuru
M
Sasako
D000230:Adenocarcinoma / Q000503:physiopathology; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D015820:Cadherins / Q000235:genetics* / Q000378:metabolism; D002166:Camptothecin / Q000031:analogs & derivatives / Q000494:pharmacology; D002273:Carcinogens / Q000633:toxicity; D000077143:Docetaxel; D005472:Fluorouracil / Q000494:pharmacology; D005849:Gerbillinae; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000378:metabolism; D006801:Humans; D000077146:Irinotecan; D008207:Lymphatic Metastasis / Q000175:diagnosis / Q000503:physiopathology; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D009154:Mutation; D009367:Neoplasm Staging; D009374:Neoplasms, Experimental / Q000503:physiopathology; D051381:Rats; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D043823:Taxoids / Q000494:pharmacology
D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D015820:Cadherins; D002273:Carcinogens; D043823:Taxoids; D000077143:Docetaxel; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin